190 related articles for article (PubMed ID: 30126359)
1. Poor prognosis of nucleophosmin overexpression in solid tumors: a meta-analysis.
Chen S; He H; Wang Y; Liu L; Liu Y; You H; Dong Y; Lyu J
BMC Cancer; 2018 Aug; 18(1):838. PubMed ID: 30126359
[TBL] [Abstract][Full Text] [Related]
2. Low microRNA-139 expression associates with poor prognosis in patients with tumors: A meta-analysis.
Chen JA; Yu Y; Xue C; Chen XL; Cui GY; Li J; Li KF; Ren ZG; Sun RR
Hepatobiliary Pancreat Dis Int; 2019 Aug; 18(4):321-331. PubMed ID: 30290990
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Significance of the Metabolic Marker Hexokinase-2 in Various Solid Tumors: A Meta-Analysis.
Liu Y; Wu K; Shi L; Xiang F; Tao K; Wang G
PLoS One; 2016; 11(11):e0166230. PubMed ID: 27824926
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of NEK2 in human solid tumors: a systematic review and meta-analysis.
Wang X; Chen K; Liu H; Huang Z; Chen X; Yin L
Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30578380
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of long non-coding RNA UCA1 in human solid tumors.
Liu FT; Zhu PQ; Luo HL; Zhang Y; Qiu C
Oncotarget; 2016 Sep; 7(36):57991-58000. PubMed ID: 27517147
[TBL] [Abstract][Full Text] [Related]
6. Tetraspanin CD151 as an emerging potential poor prognostic factor across solid tumors: a systematic review and meta-analysis.
Zeng P; Wang YH; Si M; Gu JH; Li P; Lu PH; Chen MB
Oncotarget; 2017 Jan; 8(3):5592-5602. PubMed ID: 27888619
[TBL] [Abstract][Full Text] [Related]
7. The prognostic value of HOXA13 in solid tumors: A meta-analysis.
Wen Y; Shu F; Chen Y; Chen Y; Lan Y; Duan X; Zhao SC; Zeng G
Clin Chim Acta; 2018 Aug; 483():64-68. PubMed ID: 29678634
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-10b expression predicts long-term survival in patients with solid tumor.
Zhang Y; Wang LJ; Yang HQ; Wang R; Wu HJ
J Cell Physiol; 2019 Feb; 234(2):1248-1256. PubMed ID: 30191959
[TBL] [Abstract][Full Text] [Related]
9. TMPRSS4 as an emerging potential poor prognostic factor for solid tumors: A systematic review and meta-analysis.
Zeng P; Zhang P; Zhou LN; Tang M; Shen YX; Jin J; Zhu YQ; Chen MB
Oncotarget; 2016 Nov; 7(46):76327-76336. PubMed ID: 27344186
[TBL] [Abstract][Full Text] [Related]
10. Prognostic role of STAT3 in solid tumors: a systematic review and meta-analysis.
Wu P; Wu D; Zhao L; Huang L; Shen G; Huang J; Chai Y
Oncotarget; 2016 Apr; 7(15):19863-83. PubMed ID: 26959884
[TBL] [Abstract][Full Text] [Related]
11. PBK/TOPK overexpression and survival in solid tumors: A PRISMA-compliant meta-analysis.
Xu M; Xu S
Medicine (Baltimore); 2019 Mar; 98(10):e14766. PubMed ID: 30855480
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of microRNA-145 in patients with various cancers: a meta-analysis.
Dai SL; Zhou J; Pan C; Huang G; Shi ZL; Yang SY; Yang KX
Cancer Biomark; 2015; 15(4):507-13. PubMed ID: 25792469
[TBL] [Abstract][Full Text] [Related]
13. The utility of long non-coding RNA ZEB1-AS1 as a prognostic biomarker in human solid tumors: A meta-analysis.
Zuo XL; Cai J; Chen ZQ; Zhang Y; Liang LH; Wang JF; Wang JG; Wu J; Mao JD
Clin Chim Acta; 2018 Oct; 485():14-20. PubMed ID: 29906419
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Role of High Stathmin 1 Expression in Patients with Solid Tumors: Evidence from a Meta-Analysis.
Mao Q; Chen Z; Wang K; Xu R; Lu H; He X
Cell Physiol Biochem; 2018; 50(1):66-78. PubMed ID: 30278466
[TBL] [Abstract][Full Text] [Related]
15. Prognostic role of fibroblast growth factor receptor 2 in human solid tumors: A systematic review and meta-analysis.
Liu G; Xiong D; Xiao R; Huang Z
Tumour Biol; 2017 Jun; 39(6):1010428317707424. PubMed ID: 28618942
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of periostin in multiple solid cancers: A systematic review with meta-analysis.
Yang T; Deng Z; Pan Z; Qian Y; Yao W; Wang J
J Cell Physiol; 2020 Mar; 235(3):2800-2808. PubMed ID: 31517399
[TBL] [Abstract][Full Text] [Related]
17. TIM-3 is a potential prognostic marker for patients with solid tumors: A systematic review and meta-analysis.
Zhang Y; Cai P; Liang T; Wang L; Hu L
Oncotarget; 2017 May; 8(19):31705-31713. PubMed ID: 28423646
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of FOXM1 in solid tumors: a systematic review and meta-analysis.
Li L; Wu D; Yu Q; Li L; Wu P
Oncotarget; 2017 May; 8(19):32298-32308. PubMed ID: 28427178
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of 8-hydroxy-2'-deoxyguanosine in solid tumors: a meta-analysis.
Qing X; Shi D; Lv X; Wang B; Chen S; Shao Z
BMC Cancer; 2019 Oct; 19(1):997. PubMed ID: 31651287
[TBL] [Abstract][Full Text] [Related]
20. The role of SOX2 overexpression in prognosis of patients with solid tumors: A meta-analysis and system review.
Wang S; Liu X; Chen Y; Zhan X; Wu T; Chen B; Sun G; Yan S; Xu L
Medicine (Baltimore); 2020 Mar; 99(13):e19604. PubMed ID: 32221082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]